Dimensional Fund Advisors
CGEM icon

Dimensional Fund Advisors’s Cullinan Oncology CGEM Stock Holding History

Dimensional Fund Advisors’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.9M Buy
906,028
+57,259
+7% +$736K ﹤0.01% 2165
2025
Q4 		$8.78M Sell
848,769
-335,052
-28% -$3.02M ﹤0.01% 2326
2025
Q3 		$7.02M Sell
1,183,821
-92,717
-7% -$679K ﹤0.01% 2429
2025
Q2 		$9.61M Sell
1,276,538
-26,683
-2% -$214K ﹤0.01% 2289
2025
Q1 		$9.87M Sell
1,303,221
-15,151
-1% -$145K ﹤0.01% 2256
2024
Q4 		$16.1M Buy
1,318,372
+295,467
+29% +$4.25M ﹤0.01% 2087
2024
Q3 		$17.1M Buy
1,022,905
+263,145
+35% +$4.67M ﹤0.01% 2073
2024
Q2 		$13.2M Sell
759,760
-233,617
-24% -$4.97M ﹤0.01% 2138
2024
Q1 		$16.9M Buy
993,377
+77,619
+8% +$1.2M ﹤0.01% 2071
2023
Q4 		$9.33M Buy
915,758
+117,042
+15% +$1.04M ﹤0.01% 2348
2023
Q3 		$7.23M Buy
798,716
+276,049
+53% +$2.87M ﹤0.01% 2400
2023
Q2 		$5.62M Buy
522,667
+176,448
+51% +$1.87M ﹤0.01% 2481
2023
Q1 		$3.54M Buy
346,219
+190,541
+122% +$2.1M ﹤0.01% 2590
2022
Q4 		$1.64K Buy
155,678
+144,394
+1,280% +$1.75M ﹤0.01% 2773
2022
Q3 		$145K Buy
+11,284
New +$152K ﹤0.01% 3288

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Dimensional Fund Advisors's CGEM Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Cullinan Oncology (CGEM) stake by 6.7% in Q1 2026, buying an estimated $736K and bringing the position to 906,028 shares worth $12.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2165.

Dimensional Fund Advisors first reported a position in CGEM in Q3 2022 and has held it in 15 quarters since. The position peaked at $17.1M in Q3 2024. 174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

  • Dimensional Fund Advisors held 906,028 shares of Cullinan Oncology worth $12.9M as of Q1 2026.
  • Dimensional Fund Advisors bought 57,259 Cullinan Oncology shares in Q1 2026, an estimated $736K.
  • Cullinan Oncology made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2165 holding.
  • Dimensional Fund Advisors first reported a position in Cullinan Oncology in Q3 2022 and has held it in 15 quarters since.
  • Dimensional Fund Advisors's Cullinan Oncology position peaked at $17.1M in Q3 2024.
  • 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.